The Release of Soluble Factors Contributing to Endothelial Activation and Damage after Hematopoietic Stem Cell Transplantation Is Not Limited to the Allogeneic Setting and Involves Several Pathogenic Mechanisms
Open Access
- 31 May 2009
- journal article
- Published by Elsevier BV in Transplantation and Cellular Therapy
- Vol. 15 (5), 537-546
- https://doi.org/10.1016/j.bbmt.2009.01.013
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Vascular endothelium and graft-versus-host diseaseBest Practice & Research Clinical Haematology, 2008
- Vascular endothelium as ‘novel’ target of graft-versus-host diseaseBest Practice & Research Clinical Haematology, 2008
- The Contribution of Endothelial Activation and Injury to End-Organ Toxicity following Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2008
- Allogeneic and autologous transplantation for haematological diseases, solid tumours and immune disorders: definitions and current practice in EuropeBone Marrow Transplantation, 2006
- Nonmalignant late effects after allogeneic stem cell transplantationBlood, 2003
- Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotideBlood, 2002
- Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host diseaseThe Lancet, 2002
- Engraftment syndrome following hematopoietic stem cell transplantationBone Marrow Transplantation, 2001
- Serum levels of soluble adhesion molecules in stem cell transplantation-related complicationsBone Marrow Transplantation, 2001
- INFLUENCE OF BACTERIAL ENDOTOXIN ON RADIATION-INDUCED ACTIVATION OF HUMAN ENDOTHELIAL CELLS IN VITRO AND IN VIVOTransplantation, 1996